"Erythropoietin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
Descriptor ID |
D004921
|
MeSH Number(s) |
D12.644.276.374.410.240.150 D12.776.395.240.150 D12.776.467.374.410.240.150 D23.529.374.410.240.150
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythropoietin".
Below are MeSH descriptors whose meaning is more specific than "Erythropoietin".
This graph shows the total number of publications written about "Erythropoietin" by people in this website by year, and whether "Erythropoietin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2004 | 1 | 1 | 2 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2010 | 0 | 1 | 1 |
2011 | 1 | 1 | 2 |
2013 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2017 | 9 | 12 | 21 |
2018 | 5 | 3 | 8 |
2019 | 4 | 2 | 6 |
2020 | 3 | 1 | 4 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Erythropoietin" by people in Profiles.
-
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jul 06; 22(1):435.
-
Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform. PLoS One. 2021; 16(6):e0253458.
-
Low serum erythropoietin levels are associated with fatal COVID-19 cases at 4,150 meters above sea level. Respir Physiol Neurobiol. 2021 10; 292:103709.
-
Use of face mask by blood donors during the COVID-19 pandemic: Impact on donor hemoglobin concentration: A bane or a boon. Transfus Apher Sci. 2021 Aug; 60(4):103160.
-
Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915-918. J Med Virol. 2021 05; 93(5):2626-2627.
-
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:142-151.
-
Revisiting the treatment of anemia in the setting of chronic kidney disease, hematologic malignancies, and cancer: perspectives with opinion and commentary. Expert Rev Hematol. 2020 11; 13(11):1175-1188.
-
[Erythropoietin as possible treatment of brain diseases]. Ugeskr Laeger. 2020 10 26; 182(44).
-
No Relevant Analogy Between COVID-19 and Acute Mountain Sickness. High Alt Med Biol. 2020 12; 21(4):315-318.
-
Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020 Aug; 35(8):763-773.